Systemic Antifungal Prophylaxis in Patients ...
Type de document :
Article dans une revue scientifique
PMID :
URL permanente :
Titre :
Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study.
Auteur(s) :
Gangneux, Jean-Pierre [Auteur]
El-Cheikh, Jean [Auteur]
Herbrecht, Raoul [Auteur]
Yakoub-Agha, Ibrahim [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Quiniou, Jean-Baptiste [Auteur]
Caillot, Denis [Auteur]
Michallet, Mauricette [Auteur]
El-Cheikh, Jean [Auteur]
Herbrecht, Raoul [Auteur]
Yakoub-Agha, Ibrahim [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Quiniou, Jean-Baptiste [Auteur]
Caillot, Denis [Auteur]
Michallet, Mauricette [Auteur]
Titre de la revue :
Infectious Diseases and Therapy
Nom court de la revue :
Infect Dis Ther
Numéro :
7
Pagination :
309–325
Date de publication :
2018-09
Mot(s)-clé(s) :
Invasive fungal disease
Hematology
Antifungal prophylaxis
Systemic antifungal treatment
Hematology
Antifungal prophylaxis
Systemic antifungal treatment
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Introduction: The frequency of invasive fungal diseases (IFDs) has increased in recent years. Within a context where both treatments and guidelines are fast evolving, we aim to shed new light on IFD management in hematologic ...
Lire la suite >Introduction: The frequency of invasive fungal diseases (IFDs) has increased in recent years. Within a context where both treatments and guidelines are fast evolving, we aim to shed new light on IFD management in hematologic departments in France. Methods: A multicenter cross-sectional observational study was prospectively conducted in 24 French centers in September and October 2013. Results: Four hundred ninety-four hospitalized children and adult patients suffering from hematologic malignancy were enrolled: 147 (30%) were allogeneic hematopoietic stem cell transplant (HSCT) recipients, 131 (27%) were patients with acute myeloblastic leukemia or myelodysplastic syndrome (MDS), 71 (14%) were patients with acute lymphoblastic leukemia who did not undergo allogeneic HSCT, and the 145 (29%) remaining patients did not belong to the three above groups. Two hundred forty-six patients (50%) received antifungal treatment, which was prophylactic in 187 (76%) treated patients. These rates were similar across all groups (63–80%). Patients received prophylaxis with an azole (79%), intravenous amphotericin B formulation (10%), echinocandin (9%), or two combination drugs (2%). Conclusion: Results indicate that prophylaxis is the leading antifungal strategy in French hematology units, regardless of the disease condition, representing 76% of prescriptions for antifungal therapy.Lire moins >
Lire la suite >Introduction: The frequency of invasive fungal diseases (IFDs) has increased in recent years. Within a context where both treatments and guidelines are fast evolving, we aim to shed new light on IFD management in hematologic departments in France. Methods: A multicenter cross-sectional observational study was prospectively conducted in 24 French centers in September and October 2013. Results: Four hundred ninety-four hospitalized children and adult patients suffering from hematologic malignancy were enrolled: 147 (30%) were allogeneic hematopoietic stem cell transplant (HSCT) recipients, 131 (27%) were patients with acute myeloblastic leukemia or myelodysplastic syndrome (MDS), 71 (14%) were patients with acute lymphoblastic leukemia who did not undergo allogeneic HSCT, and the 145 (29%) remaining patients did not belong to the three above groups. Two hundred forty-six patients (50%) received antifungal treatment, which was prophylactic in 187 (76%) treated patients. These rates were similar across all groups (63–80%). Patients received prophylaxis with an azole (79%), intravenous amphotericin B formulation (10%), echinocandin (9%), or two combination drugs (2%). Conclusion: Results indicate that prophylaxis is the leading antifungal strategy in French hematology units, regardless of the disease condition, representing 76% of prescriptions for antifungal therapy.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Inserm
Université de Lille
CHU Lille
Université de Lille
CHU Lille
Équipe(s) de recherche :
Immunity, inflammation and fibrsis in auto and allo-reactivity
Date de dépôt :
2019-03-01T14:34:36Z
2023-12-21T12:44:23Z
2023-12-21T12:44:23Z
Fichiers
- s40121-018-0203-4.pdf
- Non spécifié
- Accès libre
- Accéder au document